Tower Research Capital (TRC)’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Tower Research Capital (TRC)’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,807	Closed	-$71K	–	6682
2022 Q4	$71K	Buy	5,807 +5,042	+659%	+$120K	﹤0.01%	2099
2022 Q3	$25K	Sell	765 -63	-8%	-$1.78K	﹤0.01%	3780
2022 Q2	$16K	Buy	828 +381	+85%	+$7.29K	﹤0.01%	4044
2022 Q1	$8K	Buy	+447	New	+$9.17K	﹤0.01%	4652

Tower Research Capital (TRC)'s CINC Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 5,807 shares — an estimated $71K sold.

Tower Research Capital (TRC) first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $71K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Tower Research Capital (TRC) reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 5,807 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $71K.
Tower Research Capital (TRC) first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Tower Research Capital (TRC)'s CinCor Pharma, Inc. Common Stock position peaked at $71K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.